XML 46 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Investments (Tables)
9 Months Ended
Sep. 30, 2017
Equity Method Investments and Joint Ventures [Abstract]  
Schedule Of Fair Value Method Investments, Balance Sheets And Income Statements
The condensed balance sheets for kaléo at September 30, 2017 and December 31, 2016 and condensed statements of operations for the three and nine months ended September 30, 2017 and 2016, as reported to the Company by kaléo, are provided below:
Unaudited (In Thousands)
September 30, 2017
 
December 31, 2016
 
 
September 30, 2017
 
December 31, 2016
Assets:
 
 
 
 
Liabilities & Equity:
 
 
 
Cash & short-term investments
$
104,753

 
$
102,329

 
 
 
 
 
Restricted cash
31

 
31

 
Current liabilities
$
85,086

 
$
50,134

Other current assets
39,059

 
15,391

 
Long term debt, net
138,305

 
143,380

Property & equipment
10,399

 
13,011

 
Other noncurrent liabilities
807

 
822

Other long-term assets
494

 
472

 
Equity
(69,462
)
 
(63,102
)
Total assets
$
154,736

 
$
131,234

 
Total liabilities & equity
$
154,736

 
$
131,234

 
Three Months Ended September 30,
 
Nine Months Ended September 30,
Unaudited (In Thousands)
2017
 
2016
 
2017
 
2016
Revenues
$
58,822

 
$
17,377

 
$
148,761

 
$
29,347

Cost of goods sold, R&D and SG&A expenses
   before depreciation & amortization
(52,072
)
 
(19,046
)
 
(137,411
)
 
(50,442
)
Depreciation & amortization
(1,245
)
 
(1,278
)
 
(3,723
)
 
(3,477
)
Operating income (loss)
5,505

 
(2,947
)
 
7,627

 
(24,572
)
Gain on contract termination

 

 

 
18,075

Net interest expense and other net
(4,767
)
 
(4,848
)
 
(14,408
)
 
(14,535
)
Income tax benefit (expense)
(244
)
 

 
(734
)
 
(8
)
Net income (loss)
$
494

 
$
(7,795
)
 
$
(7,515
)
 
$
(21,040
)